These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 31164100)
1. Different EPHX1 methylation levels in promoter area between carbamazepine-resistant epilepsy group and carbamazepine-sensitive epilepsy group in Chinese population. Lv Y; Zheng X; Shi M; Wang Z; Cui L BMC Neurol; 2019 Jun; 19(1):114. PubMed ID: 31164100 [TBL] [Abstract][Full Text] [Related]
2. Association of ABCB1, CYP3A4, EPHX1, FAS, SCN1A, MICA, and BAG6 polymorphisms with the risk of carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in Chinese Han patients with epilepsy. He XJ; Jian LY; He XL; Tang M; Wu Y; Xu YY; Sun XJ; Zhao LM Epilepsia; 2014 Aug; 55(8):1301-6. PubMed ID: 24861996 [TBL] [Abstract][Full Text] [Related]
3. Effects of EPHX1, SCN1A and CYP3A4 genetic polymorphisms on plasma carbamazepine concentrations and pharmacoresistance in Chinese patients with epilepsy. Yun W; Zhang F; Hu C; Luo X; Xue P; Wang J; Ge Y; Meng H; Guo Y Epilepsy Res; 2013 Dec; 107(3):231-7. PubMed ID: 24125961 [TBL] [Abstract][Full Text] [Related]
4. Polymorphic Variants of SCN1A and EPHX1 Influence Plasma Carbamazepine Concentration, Metabolism and Pharmacoresistance in a Population of Kosovar Albanian Epileptic Patients. Daci A; Beretta G; Vllasaliu D; Shala A; Govori V; Norata GD; Krasniqi S PLoS One; 2015; 10(11):e0142408. PubMed ID: 26555147 [TBL] [Abstract][Full Text] [Related]
5. Effects of EPHX1 and CYP3A4*22 genetic polymorphisms on carbamazepine metabolism and drug response among Tunisian epileptic patients. Chbili C; Fathallah N; Laouani A; Nouira M; Hassine A; Ben Amor S; Ben Ammou S; Ben Salem C; Saguem S J Neurogenet; 2016 Mar; 30(1):16-21. PubMed ID: 27276192 [TBL] [Abstract][Full Text] [Related]
6. ABCB1 c.3435C > T and EPHX1 c.416A > G polymorphisms influence plasma carbamazepine concentration, metabolism, and pharmacoresistance in epileptic patients. Zhang ML; Chen XL; Bai ZF; Zhao X; Li WX; Wang XY; Zhang H; Chen XF; Zhang SQ; Tang JF; Xiao XH; Zhao YL Gene; 2021 Dec; 805():145907. PubMed ID: 34411648 [TBL] [Abstract][Full Text] [Related]
7. Influence of Venkatraman S; Ramasamy K; Nair PP; Rajendran P Drug Metab Pers Ther; 2023 Jun; 38(2):191-197. PubMed ID: 36853909 [TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphisms of microsomal epoxide hydrolase and UDP-glucuronosyltransferase (UGT) and its effects on plasma carbamazepine levels and metabolic ratio in persons with epilepsy of South India: A cross-sectional genetic association study. Venkatraman S; Ramasamy K; Nair PP Indian J Pharmacol; 2023; 55(3):149-154. PubMed ID: 37555408 [TBL] [Abstract][Full Text] [Related]
10. Association between EPHX1 polymorphisms and carbamazepine metabolism in epilepsy: a meta-analysis. Zhao GX; Shen ML; Zhang Z; Wang P; Xie CX; He GH Int J Clin Pharm; 2019 Dec; 41(6):1414-1428. PubMed ID: 31650507 [TBL] [Abstract][Full Text] [Related]
11. Association of EPHX1 polymorphisms with plasma concentration of carbamazepine in epileptic patients: Systematic review and meta-analysis. Hu T; Zeng X; Tian T; Liu J J Clin Neurosci; 2021 Sep; 91():159-171. PubMed ID: 34373022 [TBL] [Abstract][Full Text] [Related]
12. Haplotype structures of EPHX1 and their effects on the metabolism of carbamazepine-10,11-epoxide in Japanese epileptic patients. Nakajima Y; Saito Y; Shiseki K; Fukushima-Uesaka H; Hasegawa R; Ozawa S; Sugai K; Katoh M; Saitoh O; Ohnuma T; Kawai M; Ohtsuki T; Suzuki C; Minami N; Kimura H; Goto Y; Kamatani N; Kaniwa N; Sawada J Eur J Clin Pharmacol; 2005 Mar; 61(1):25-34. PubMed ID: 15692831 [TBL] [Abstract][Full Text] [Related]
13. Effects of major transporter and metabolizing enzyme gene polymorphisms on carbamazepine metabolism in Chinese patients with epilepsy. Zhu X; Yun W; Sun X; Qiu F; Zhao L; Guo Y Pharmacogenomics; 2014; 15(15):1867-79. PubMed ID: 25495409 [TBL] [Abstract][Full Text] [Related]
14. Association of polymorphisms in EPHX1, UGT2B7, ABCB1, ABCC2, SCN1A and SCN2A genes with carbamazepine therapy optimization. Hung CC; Chang WL; Ho JL; Tai JJ; Hsieh TJ; Huang HC; Hsieh YW; Liou HH Pharmacogenomics; 2012 Jan; 13(2):159-69. PubMed ID: 22188362 [TBL] [Abstract][Full Text] [Related]
15. Association of carbamazepine major metabolism and transport pathway gene polymorphisms and pharmacokinetics in patients with epilepsy. Puranik YG; Birnbaum AK; Marino SE; Ahmed G; Cloyd JC; Remmel RP; Leppik IE; Lamba JK Pharmacogenomics; 2013 Jan; 14(1):35-45. PubMed ID: 23252947 [TBL] [Abstract][Full Text] [Related]
16. Association between PK/PD-involved gene polymorphisms and carbamazepine-individualized therapy. Ma CL; Jiao Z; Wu XY; Hong Z; Wu ZY; Zhong MK Pharmacogenomics; 2015; 16(13):1499-512. PubMed ID: 26314341 [TBL] [Abstract][Full Text] [Related]
17. Effects of CYP3A4/5 and ABCB1 genetic polymorphisms on carbamazepine metabolism and transport in Chinese patients with epilepsy treated with carbamazepine in monotherapy and bitherapy. Wang P; Yin T; Ma HY; Liu DQ; Sheng YH; Wang C; Zhou BT Epilepsy Res; 2015 Nov; 117():52-7. PubMed ID: 26421491 [TBL] [Abstract][Full Text] [Related]
18. Effects of ABCB1 polymorphisms on plasma carbamazepine concentrations and pharmacoresistance in Chinese patients with epilepsy. Meng H; Guo G; Ren J; Zhou H; Ge Y; Guo Y Epilepsy Behav; 2011 May; 21(1):27-30. PubMed ID: 21493161 [TBL] [Abstract][Full Text] [Related]
19. Drug-resistant epilepsy in children with partial onset epilepsy treated with carbamazepine. Aungaroon G; Holland KD; Horn PS; Standridge SM; Imming CM Int J Neurosci; 2017 Oct; 127(10):849-853. PubMed ID: 27915489 [TBL] [Abstract][Full Text] [Related]
20. Association of MDR1 (C3435T) polymorphism and resistance to carbamazepine in epileptic patients from Turkey. Ozgon GO; Bebek N; Gul G; Cine N Eur Neurol; 2008; 59(1-2):67-70. PubMed ID: 17917461 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]